About EBSA13 Conference Ljubljana

EBSA13 Conference Ljubljana



09.00 - 09.30
Opening and introduction

Dr. Samo Kopac, Environment Directorate of the Ministry of the Environment and
Spatial Planning, Ljubljana/SLO

Ingegerd Kallings, Swedish Institute for Infectious Disease Control, Stockholm/S
EBSA President 2009 - 2010
Session 1: GMOs, public health and the environment
09.30 - 10.00
Science-based GM risk assessment
Michael Skinner, Imperial College London/UK
10.00 - 10.30 h
Problem formulation in the environmental risk assessment for GM crops
Alan Gray, Centre for Ecology and Hydrology, Wallingford/UK
changed on 21.05.2010
10.30 - 11.00
Coffee break
Session 2: Sustainable design
11.00 - 11.30
Are green issues compatible with biocontainment
Heather Sheeley, Health Protection Agency, Salisbury/UK
11.30 - 12.00
Issues of sustainability in containment
Mark Bryan, HDR - CUH2A, London/UK
12.00 - 13.00
Session 3 (seven parallel):
Breakout session  
13.00 - 14.30
Breakout Session A
Sampling detection

Patrick Rüdelsheim, Perseus BVBA, Zwijnaarde/B
Louis Seechurn, Manchester University/UK

Short description:
Sampling and detection associated with inspections at containment facilities are still in a developmental phase and its application is fragmentary, but more countries are considering it. The purpose of this break-out group is to exchange experience with such activities, the use of different sampling and detection methodologies and their limitations for GMOs and pathogens, validation of testing facilities; and with the analysis of results from a risk management perspective.
Breakout Session B
CEN Workshop 53 'Biosafety Professional Competence': EBSA's initiative towards a certified profession

Helmut Bachmayer, Maria Enzersdorf/A
Ursula Jenal, Jenal & Partners Biosafety Consulting, Rheinfelden/CH

Short description:
The EU directives state that a competent individual needs to be appointed to coordinate and provide advice and guidance on biosafety management issues. The definition of what exactly is meant by a 'competent individual' and how this status is achieved, is not defined. In order to address this lack of guidance for BSP, EBSA's BSP working group has developed a draft BSP competence document describing the tasks of a BSP, the competence required to fulfill these tasks and a training program with which this competence can be gained. The BSP competence document has become the basis for a CEN workshop agreement process. CEN Workshop 53 'Biosafety Professional Competence' has started on December 19th, 2009, and EBSA members are still welcome to participate in the workshop process which will last until May 2011. At this breakout session, the CEN WS 53 BSP competence draft document will be presented and the main discussion points will be highlighted. Input to the discussion from the participants of the breakout session will be highly welcome.
Breakout Session C
Guidance CWA 15793

Ingegerd Kallings, Swedish Institute for Infectious Disease Control, Stockholm/S
Martin Kuster, Novartis International AG, Basel/CH

Short description:
The Laboratory Biorisk Management Standard CWA 15793:2008 has evoked much interest all over the world in a variety of laboratory settings. However, a need for guidance for laboratory managers in understanding and implementing the CWA 15793:2008 has been identified and a CEN Workshop N 55 is to start 24 February, 2010 followed on 25 February by the 1st plenary meeting, financially supported by the Canadian Government, ABSA and EBSA. The guidance document aims to:
i) Ensure that users of CWA 15793:2008 are able to easily understand and confidently implement all aspects of the CWA thus increasing the use of the CWA,
ii) Increase the confidence of stakeholders including regulators, funding organizations and the community, that there is consistency in the application of the CWA in laboratories.
This session will give a review of the 1st plenary meeting, describe and discuss the process. Contributions to the discussion are welcom
Breakout Session D  
Building confidence between the BSP and the scientist

Vibeke Halkjær-Knudsen, Statens Serum Institute Copenhagen/DK

changed on 17.05.2010 Short description:
The interests of the BSP and the scientist can be in conflict. For the BSP the safety of the workers and processes, rules and regulations are important. The scientist is, most probably, only interested in the progress of his (or her) research projects. For him it is publish or perish. Most often, the scientist's opinion is that rules, regulations, permits, the BSP and even sometimes safety issues will slow down this progress. To do his work properly, the BSP should get all the required information for risk assessment, to ensure compliance of the research projects with rules and regulation via an open communication with the scientist. One way to accomplish this, is by mutual trust or confidence between the scientist and the BSP. During the break-out session we will explore several methods to gain this mutual confidence and what steps a BSP can take to earn the confidence of the scientist, vice versa. Participants are invited to contribute to the discussion by giving practical examples what worked (or not worked) in their situation to build a relationship based on confidence between the BSP and the scientist.
Breakout Session E  
Sharing experience of LAI, recent and past

Heather Sheeley, Health Protection Agency, Salisbury/UK

Short description:
Accidents leading to injuries or illness still happen, despite excellent preventative measures and risk assessments. However, if accidents/disease go not reported and are not worked up, unsafe conditions or unsafe workpractices may continue and give rise to additional accidents/illnesse.
In a bio-safety setting, consequences to the individual can be serious and can even develop into a threat to public health.
Participants will develop the important elements of an incident reporting and working up scheme and discuss in particular:
- What policies should be there, what should be the main content
- What structures are necessary to implement the policies: format, who is involved
- Once an incident happened, what are the steps to be taken: for the individual, for the line management, for the BSO/HSEO
Breakout Session F  
Containment design and testing for novel equipment
Allan Bennett, Health Protection Agency, Salisbury/UK
Simon Parks, Health Protection Agency, Salisbury/UK
Short description:
This breakout session will run in two parts. The first will deal with how to establish when it is necessary to place equipment into primary containment by assessing the potential for aerosol generation or the potential for surface contamination under both nominal and accidental conditions. If there is the potential for contamination then this workshop will discuss which primary containment measures are available and matters to be considered during selection. The second part of the session will deal with how to test the efficacy of the containment equipment and some of the design issues highlighted during testing.
Breakout Session G
Plant containment (greenhouses and growth rooms)

Benedictus J.M. Verduin, Wageningen University and Research centre, Wageningen/NL

Short description:
Containment of plants in greenhouses and growth rooms is legally required after genetic modification of plants or during activities with plants associated with genetically modified plant pathogens and/or plant quarantine material. What determinants are critical for assigning a certain containment level (BSL 1, 2 or 3)? How is ventilation regulated either keeping the pollen/seeds/insect in or out? What about handling waste water including small seeds? What about handling large volumes of solid waste with or without plant quarantine material? Any other questions regarding containment of plants? Join the session if you have a contribution or if you are interested in the discussion resulting in recommendations.
14.30 - 15.00
Coffee break and posters
Session 4: Biosecurity public communication
15.00 - 15.30
Controlling international transfers of biological agents, manufacturing facilities and equipment: an essential element of biosecurity
Ian Anthony, SIPRI, Solna/S
15.30 - 16.00
Public participation, convention of Aarhus and GMOs
Fiona Marshall, Commision for Europe Environmental Affairs Officer, Geneva/CH
Session 5: Chris Collins Lecture  
16.00 - 16.45
Determinants of virulence in zoonotic and pandemic influenza viruses
Sander Herfst, Erasmus Medical Center, Rotterdam/NL
17.00 - 18.00
Conference dinner at the Ljubljana Castle


Session 6: Applied biosafety
09.00 - 09.30
Biorisk Management at SPIEZ LABORATORY - concept and training
changed on 16.06.2010
09.30 - 10.00
Biowaste treatment technologies
Claude Sigwalt, Actini SAS , Evian/F
10.00 - 10.30
Decontamination of small spaces and tubes
Steve Devine , Camfil Farr Inc., Riverdale, NJ/USA; K. Woolard, Camfil Farr Inc., Washington, NC/USA;
A. Mahler, Camfil Farr KG, Reinfeld/D
10.30 - 11.00
Coffee break
11.00 - 11.30
Report on Breakouts
Session 7:
Regulatory frameworks for working with human pathogens, animal pathogens and genetically modified organisms in containment
11.30 - 13.00
Experience in UK 
Developing a single regulatory framework for working with human pathogens, animal pathogens and genetically modified organisms in containment
Lorraine Medcalf, Jonathan M. Gawn, John Newbold, Health and Safety Executive, Liverpool/UK
Experience in Belgium
Experience with a combined legislation for pathogens and GMOs
Philippe Herman, SIPH - Service of Biosafety and Biotechnology, Brussels/B
Experience in Slovenia
Critical reflections on biosafety in Slovenia towards regulatory harmonisation- effectiveness, consequences and weaknesses
R. Rupreht, Ministry of the Environment and Spatial Planning, Ljubljana/SLO; M. Milavec, National Institute of Biology, Ljubljana/SLO; D. Stanic Racman, M. Batic, Ministry of the Environment and Spatial Planning, Ljubljana/SLO
13.00 - 14.00
Session 8: New and emerging issues
14.00 - 14.30
Development and application of a novel risk-model for risk assessment of activities with biological agents and its integration into a GIS-based risk register
D. Müller , Basler & Hofmann Consulting Engineers, Zurich/CH; F.K. Gmuender, Basler & Hofmann Singapore Pte Ltd/SGP; A. Schoenenberger, Basler & Hofmann Consulting Engineers, Zurich/CH; D. Fischer, K. Fischer, Cantonal Office of Waste, Water, Energy and Air, Biosafety Unit, Zurich/CH; A. Susini, Geneva Environmental Rescue Service (SIE), Canton of Geneva, Geneva/CH; E. Dumermuth, U. Voegeli, Cantonal Laboratory, Basel/CH
14.30 - 15.00
Assessment of the risk of aerosol transmission of influenza in intensive care units
Alan Bennett, Health Protection Agency, Salisburg/UK
Closing remarks EBSA President 2010 - 2011